Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects

Growth Hormone and IGF Research

Volumn 13, Issue 2-3, 2003, Pages 55-74

  Møller, Jens ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; GROWTH HORMONE; INSULIN; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN; RENIN; SODIUM; SOMATOMEDIN C;

ACROMEGALY; ADENOHYPOPHYSIS; CAPILLARY; DOWN REGULATION; EXTRACELLULAR SPACE; FLUID BALANCE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE FUNCTION; HORMONE SUBSTITUTION; HUMAN; HYDROSTATIC PRESSURE; HYPERINSULINEMIA; HYPOTHESIS; IN VITRO STUDY; INHIBITION KINETICS; INOTROPISM; INSULIN RESISTANCE; INTERSTITIAL FLUID; KIDNEY TUBULE FUNCTION; NATRIURESIS; NONHUMAN; ONCOTIC PRESSURE; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIDE EFFECT; SODIUM RETENTION; THEORY; TOTAL BODY WATER; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 0038173653     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00011-X     Document Type: Review

References (229)

1. G.L. Robertson, T. Berl, Pathophysiology of water metabolism, in: B.M. Brenner (Ed.), The Kidney, WB Saunders, Philadelphia, 1996, pp. 873-928.
2. M.L. McManus, K.B. Churchwell, K. Strange, Regulation of cell volume in health and disease, N. Engl. J. Med. 333 (1995) 1260-1266.
3. A.C. Guyton, J.E. Hall, Transport of ions and molecules through the cell membrane, in: A.C. Guyton, J.E. Hall (Eds.), Textbook of Medical Physiology, WB Saunders, Philadelphia, 1996, pp. 43-54.
4. A.C. Guyton, J.E. Hall, The body fluid compartments: extracellular and intracellular fluids; interstitial fluids and edema, in: A.C. Guyton, J.E. Hall (Eds.), Textbook of Medical Physiology, WB Saunders, Philadelphia, 1996, pp. 297-313.
5. W.G. Downs, E.M.K. Geiling, Possible water balance; effects of alkaline anterior pituitary extracts, Proc. Soc. Exp. Biol. Med. 27 (1929) 63-64.
6. D. Ikkos, R. Luft, B. Sjogren, Body water and sodium in patients with acromegaly, J. Clin. Invest. 33 (1954) 989-994.
7. J.C. Beck, E.E. McGarry, J. Dyrenfurth, E.H. Venning, Metabolic effects of human and monkey growth hormone in man, Science 125 (1957) 884-885.
8. J.C. Beck, E.E. McGarry, J. Dyrenfurth, E.H. Venning, The metabolic effect of human and monkey growth hormone in man, Ann. Int. Med. 49 (1958) 1090-1105.
9. J.J. Hutchings, R.F. Escamilla, W.C. Deamer, C.H. Li, Metabolic changes produced by human growth hormone (Li) in a pituitary dwarf, J. Clin. Endocrinol. Metab. 19 (1959) 759-769.
10. D. Ikkos, R. Luft, C.-A. Gemzell, The effect of human growth hormone in man, Acta Endocrinol. 32 (1959) 341-361.
11. P.H. Henneman, A.P. Forbes, M. Moldawer, E.F. Dempsey, E.L. Carroll, Effects of human growth hormone in man, J. Clin. Invest. 37 (1960) 1223-1245.
12. J.C. Beck, E.E. McGarry, J. Dyrenfurth, R.O. Morgen, E.D. Bird, E.H. Verining, Primate growth hormone studies in man, Metabolism 9 (1960) 699-737.
13. D.M. Bergenstal, M.B. Lipsett, Metabolic effects of human growth hormone and growth hormone of other species in man, J. Clin. Endocrinol. Metab. 20 (1960) 1427-1436.
14. E.G. Biglieri, C.O. Watlington, P.H. Forsham, Sodium retention with human growth hormone and its subtractions, J. Clin. Endocrinol. Metab. 21 (1961) 211-225.
15. J. Moller, J.O. Jorgensen, N. Moller, K.W. Hansen, E.B. Pedersen, J.S. Christiansen, Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man, J. Clin. Endocrinol. Metab. 72 (1991) 768-772.
16. B. Tonshoff, R. Nowack, S. Kurilenko, W.F. Blum, H.W. Seyberth, O. Mehls, E. Ritz, Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids, Am. J. Kidney Dis. 21 (1993) 145-151.
17. H.P. Guler, C. Schmid, J. Zapf, E.R. Froesch, Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects, Proc. Natl. Acad. Sci. USA 86 (1989) 2868-2872.
18. R.H. Boger, C. Skamire, S.M. Bode-Boger, G. Brabrant, A. von zur Muhlen, J.C. Frolich, Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind placebo controlled study, J. Clin. Invest. 98 (1996) 2706-2713.
19. D.A. Schoeller, Hydrometry, in: A.F. Roche, S.B. Heymsfield, T.G. Lohman (Eds.), Human Body Composition, Human Kinetics, Champaign, IL, 1996, pp. 25-44.
20. A. Bruce, M. Andersson, B. Arvidsson, B. Isaksson, Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age, Scand. J. Clin. Lab. Invest. 40 (1980) 461-473.
21. H.C. Lukaski, P.E. Johnson, A simple, inexpensive method of determining total body water using a tracer dose of D20 and infrared absorption of biological fluids, Am. J. Clin. Nutr. 41 (1985) 363-370.
22. A. Godtfredsen, Ikke invasiv maaling af kropssammensætning (non invasive measurement of body composition), Ugeskr. Laeger. 156 (1994) 4018-4025.
23. R.J. Brummer, T. Rosen, I. Bosaeus, B.Å. Bengtson, comparison of body composition determinations using bioelectrical impedance analysis and a four compartment model in adult growth hormone deficiency, Endocrinol. Metab. 2 (1995) 127-134.
24. D.A. Brodie, Techniques of measurement of body composition. Part I, Sports Med. 5 (1988) 11-40.
25. H.P. Sheng, R.A. Huggins, A review of body composition studies with emphasis on total body water and fat, Am. J. Clin. Nutr. 32 (1979) 630-647.
26. 24Na, Clin. Sci. 12 (1953) 97-111.
27. D.M. Hoffman, L. Crampton, C. Sernia, T.V. Nguyen, K.Y. Ho, Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure, J. Clin. Endocrinol. Metab. 81 (1996) 1123-1128.
28. B.B. Brodie, E. Brand, S. Leshin, The use of bromide as a measure of extracellular fluid, J. Biol. Chem. 130 (1939) 555-563.
29. M.E. Miller, J.M. Cosgriff, G.B. Forbes, Bromide space determination using anion-exchange chromatography for measurement of bromide, Am. J. Clin. Nutr. 50 (1989) 168-171.
30. C. Binder, A. Leth, The distribution volume of 82Br- as a measurement of the extracellular fluid volume in normal persons, Scand. J. Clin. Lab. Invest. 25 (1970) 291-297.
31. J.F. Aloia, M.S. Roginsky, J. Jowsey, C.S. Dombrowski, K.K. Shukla, S.H. Cohn, Skeletal metabolism and body composition in akromegaly, J. Clin. Endocrinol. Metab. 35 (1972) 543-551.
32. I. Bent-Hansen, Initial plasma disappearance and distribution volume of [131I]albumin and [125I]fibrinogen in man, Acta Physiol. Scand. 136 (1989) 455-461.
33. D. Ernest, N.G. Hartman, C.P. Deane, A.S. Belzberg, P.M. Dodek, Reproducibility of plasma and extracellular fluid volume measurements in critically ill patients, J. Nucl. Med. 33 (1992) 1468-1471.
34. M.W. Busse, S. Zisowsky, S. Henschen, B. Panning, S. Piepenbrock, Plasma volume estimation using indocyanine green. A single intravenous injection method, Anaesthesia 48 (1993) 41-43.
35. J. Farjanel, C. Denis, J.C. Chatard, A. Geyssant, An accurate method of plasma volume measurement by direct analysis of Evans blue spectra in plasma without dye extraction: origins of albumin-space variations during maximal exercise, Eur. J. Appl. Physiol. 75 (1997) 75-82.
36. J.S. Davies, W. Bell, W. Evans, R.J. Villis, M.F. Scanlon, Body composition derived from whole body counting of potassium in growth hormone-deficient adults: a possible low intracellular potassium concentration, J. Clin. Endocrinol. Metab. 81 (1996) 1720-1723.
37. D.A. Brodie, Techniques of measurement of body composition. Part II, Sports Med. 5 (1988) 74-98.
38. G. Hudash, J.P. Albright, E. McAuley, R.K. Martin, M. Fulton, Cross-sectional thigh components: computerized tomographic assessment, Med. Sci. Sports Exerc. 17 (1985) 417-421.
39. N. Mitsiopoulos, R.N. Baumgartner, S.B. Heymsfield, W. Lyons, D. Gallagher, R. Ross, Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, [see comments], J. Appl. Physiol. 85 (1998) 115-122.
40. C.M. Engstrom, G.E. Loeb, J.G. Reid, W.J. Forrest, L. Avruch, Morphometry of the human thigh muscles. A comparison between anatomical sections and computer tomographic and magnetic resonance images, J. Anat. 176 (1991) 139-156, 139-156.
41. P.A. Bottomley, T.H. Foster, R.E. Argersinger, L.M. Pfeifer, A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1 to 100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age, Med. Phys. 11 (1984) 425-448.
42. J.F. Polak, F.A. Jolesz, D.F. Adams, NMR of skeletal muscle. Differences in relaxation parameters related to extracellular/intracellular fluid spaces, Invest. Radiol. 23 (1988) 107-112.
43. Y.E. Snel, R.J. Brummer, M.E. Doerga, P.M.J. Zelissen, C.J.G. Bakker, M.J. Hendriks, H.P.F. Koppeschaar, Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects, Am. J. Clin. Nutr. 61 (1995) 1290-1294.
44. A. Eliakim, J.A. Brasel, S. Mohan, W.L.T. Wong, D.M. Cooper, Increased physical activity and the growth hormone-IGF-I axis in adolescent males, Am. J. Physiol. 275 (1998) R308-R314.
45. Y.J. Janssen, J. Doornbos, F. Roelfsema, Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency, J. Clin. Endocrinol. Metab. 84 (1999) 279-284.
46. D.S. Lewis, W.L. Rollwitz, H.A. Bertrand, E.J. Masoro, Use of NMR for measurement of total body water and estimation of body fat, J. Appl. Physiol. 60 (1986) 836-840.
47. I. Bosaeus, G. Johannsson, T. Rosen, P. Hallgren, J. Tolli, L. Sjostrom, B.A. Bengtsson, Comparison of methods to estimate body fat in growth hormone-deficient adults, Clin. Endocrinol. (Oxf.) 44 (1996) 395-402.
48. J. Haarbo, A. Gotfredsen, C. Hassager, C. Christiansen, Validation of body composition by dual energy X-ray absorptiometry (DEXA), Clin. Physiol. 11 (1991) 331-341.
49. M.D. Jensen, J.A. Kanaley, L.R. Roust, P.C. O'Brien, J.S. Braun, W.L. Dunn, H.W. Wahner, Assessment of body composition with use of dual-energy X-ray absorptiometry: evaluation and comparison with other methods, Mayo Clin. Proc. 68 (1993) 867-873.
50. R. Wellens, W.C. Chumlea, S. Guo, A.F. Roche, N.V. Reo, R.M. Siervogel, Body composition in white adults by dual-energy X-ray absorptiometry, densitometry, and total body water, Am. J. Clin. Nutr. 59 (1994) 547-555.
51. R. Roubenoff, J.J. Kehayias, B. Dawson-Hughes, S.B. Heymsfield, Use of dual-energy X-ray absorptiometry in body composition studies: not yet a 'gold standard', Am. J. Clin. Nutr. 58 (1993) 589-591.
52. B.M. Prior, K.J. Cureton, C.M. Modlesky, E.M. Evans, M.A. Sloniger, M. Saunders, R.D. Lewis, In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry, J. Appl. Physiol. 83 (1997) 623-630.
53. R.J. Brummer, T. Rosen, B.A. Bengtsson, Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders, Acta Endocrinol. Copenh. 128 (Suppl 2) (1993) 30-36.
54. A. De Lorenzo, A. Andreoli, J. Matthie, P. Withers, Predicting body cell mass with bioimpedance by using theoretical methods: a technological review [published erratum appears in J. Appl. Physiol. 83 (6) (1997): following table of contents], J. Appl. Physiol. 82 (1997) 1542-1558.
55. B.J. Thomas, L.C. Ward, B.H. Cornish, Bioimpedance spectrometry in the determination of body water compartments: accuracy and clinical significance, Appl. Radiat. Isot. 49 (1998) 447-455.
56. H. De Boer, G.J. Blok, H.J. Voerman, P.M. De Vries, E.A. van der Veen, Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis, J. Clin. Endocrinol. Metab. 75 (1992) 833-837.
57. H. De Boer, G.J. Blok, E.A. van der Veen, Clinical aspects of growth hormone deficiency in adults, Endocr. Rev. 16 (1995) 63-86.
58. Y.J.H. Janssen, P. Deurenberg, F. Roelfsema, Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults, J. Clin. Endocrinol. Metab. 82 (1997) 3349-3355.
59. Y.E. Snel, R.J. Brummer, M.E. Doerga, P.M. Zelissen, H.P. Koppeschaar, Validation of extracellular water determination by bioelectrical impedance analysis in growth hormone-deficient adults, Ann. Nutr. Metab. 39 (1995) 242-250.
60. R.J. Brummer, B.A. Bengtsson, I. Bosaeus, Validation of body composition determination by bioelectrical impedance analysis in acromegaly, Eur. J. Clin. Nutr. 46 (1992) 47-52.
61. H. De Boer, G.J. Blok, H.J. Voerman, P.M. De Vries, C. Popp-Snijders, E.A. van der Veen, The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis, J. Clin. Endocrinol. Metab. 80 (1995) 2069-2076.
62. D. Rudman, S.B. Chyatte, J.H. Patterson, G.G. Gerron, I. O'Beirne, J. Barlow, P. Ahmann, A. Jordan, R.C. Mosteller, Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotonic dystrophy, J. Clin. Invest. 50 (1971) 1941-1949.
63. J.L. Thompson, G.E. Butterfield, U.K. Gylfadottir, J. Yesavage, R. Marcus, R. Hintz, A. Pearman, A.R. Hoffman, Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women, J. Clin. Endocrinol. Metab. 83 (1998) 1477-1484.
64. M. Lampit, T. Nave, Z. Hochberg, Water and sodium retention during short-term administration of growth hormone to short normal children, Horm. Res. 50 (1998) 83-88.
65. K.E. Yarasheski, J.J. Zachwieja, J.A. Campbell, D.M. Bier, Effect of growth hormone and resistance exercise on muscle growth and strength in older men, Am. J. Physiol. 268 (1995) E268-E276.
66. K.E. Yarasheski, J.A. Campbell, K. Smith, M.J. Rennie, J.O. Holloszy, D.M. Bier, Effect of growth hormone and resistance exercise on muscle growth in young men, Am. J. Physiol. 262 (1992) E261-E267.
67. N. Vaisman, Z. Zadik, Y. Shamai, L. Franklin, R. Dukhan, Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone, Metabolism 41 (1992) 483-486.
68. J. Moller, J.O.L. Jørgensen, E. Frandsen, T. Laursen, J.S. Christiansen, Body fluids, circadian blood pressure, and plasma renin during growth hormone administration: a placebo controlled study with two growth hormone doses in healthy adults, Scand. J. Clin. Lab. Invest. 55 (1995) 663-669.
69. J. Moller, N. Moller, E. Frandsen, T. Wolthers, J.O. Jorgensen, J.S. Christiansen, Blockade of the renin-angiotensin-aidosterone system prevents growth hormone-induced fluid retention in humans, Am. J. Physiol. 272 (1997) E803-E808.
70. P.J. Finn, L.D. Plank, M.A. Clark, A.B. Connolly, G.L. Hill, Progressive cellular dehydration and proteolysis in critically ill patients, Lancet 347 (1996) 654-656.
71. R.N. Garrison, M.A. Wilson, P.J. Matheson, D.A. Spain, Preoperative saline loading improves outcome after elective, noncardiac surgical procedures, Am. Surg. 62 (1996) 223-231.
72. M.G. Mythen, A.R. Webb, Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery, Arch. Surg. 130 (1995) 423-429.
73. S. Sinclair, S. James, M. Singer, Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial, BMJ 315 (1997) 909-912.
74. C. Gatzen, M.R. Scheltinga, T.D. Kimbrough, D.O. Jacobs, D.W. Wilmore, Growth hormone attenuates the abnormal distribution of body water in critically ill patients, Surgery 112 (1992) 181-187.
75. M. Schambelan, K. Mulligan, C. Grunfeld, E.S. Daar, A. LaMarca, D.P. Kotler, J. Wang, S.A. Bozzette, J.B. Breitmeyer, Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group [see comments], Ann. Intern. Med. 125 (1996) 873-882.
76. L. Ellegard, I. Bosaeus, S. Nordgren, B.A. Bengtsson, Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome, Ann. Surg. 225 (1997) 88-96.
77. K.J. Ellis, P.D.K. Lee, J.M. Pivarnik, J.G. Bukar, N. Gesundheit, Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone, J. Clin. Endocrinol. Metab. 81 (1996) 3033-3038.
78. J. Møller, M.B. Jensen, E. Frandsen, N. Møller, P. Kissmeyer, S. Laurberg, Growth hormone treatment improves body fluid distribution in patients undergoing elective abdominal surgery, Clin. Endocrinol. Oxf. 47 (1998) 112-117.
79. J. Takala, E. Ruokonen, N.R. Webster, M.S. Nielsen, D.F. Zandstra, G. Vundelinckx, C.J. Hinds, Increased mortality associated with growth hormone treatment in critically III adults, N. Engl. J. Med. 341 (1999) 785-792.
80. J.O. Jorgensen, S.A. Pedersen, L. Thuesen, J. Jorgensen, T. Ingemann Hansen, N.E. Skakkebaek, J.S. Christiansen, Beneficial effects of growth hormone treatment in GH-deficient adults, Lancet 1 (1989) 1221-1225.
81. F. Salomon, R.C Cuneo, R. Hesp, P.H. Sonksen, The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency, N. Engl. J. Med. 321 (1989) 1797-1803.
82. H.M. Whitehead, C. Boreham, E.M. McIlrath, B. Sheridan, L. Kennedy, A.B. Atkinson, D.R. Hadden, Growth hormone treatment of adults with growth hormone deficiency; results of a 13-month placebo controlled cross-over study, Clin. Endocrinol. Oxf. 36 (1992) 45-52.
83. B.A. Bengtsson, S. Eden, L. Lonn, H. Kvist, A. Stokland, G. Lindstedt, I. Bosaeus, J. Tolli, L. Sjostrom, O.G. Isaksson, Treatment of adults with growth hormone (GH) deficiency with recombinant human GH, J. Clin. Endocrinol. Metab. 76 (1993) 309-317.
84. R.C. Cuneo, F. Salomon, G.A. McGauley, P.H. Sonksen, The growth hormone deficiency syndrome in adults, Clin. Endocrinol. Oxf. 37 (1992) 387-397.
85. A. Parra, R.M. Argote, G. Garcia, C. Cervantes, S. Alatorre, E. Perez Pasten, Body composition in hypopituitary dwarfs before and during human growth hormone therapy, Metabolism 28 (1979) 851-857.
86. T. Rosen, I. Bosaeus, J. Tolli, G. Lindstedt, B.A. Bengtson, Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency, Clin. Endocrinol. 38 (1993) 63-71.
87. A. Binnerts, P. Deurenberg, G.R. Swart, J.H. Wilson, S.W. Lamberts, Body composition in growth hormone-deficient adults, Am. J. Clin. Nutr. 55 (1992) 918-923.
88. D.M. Hoffman, A.J. O'Sullivan, J. Freund, K.Y. Ho, Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism, J. Clin. Endocrinol. Metab. 80 (1995) 72-77.
89. J. Moller, E. Frandsen, S. Fisker, J.O.L. Jørgensen, J.S. Christiansen, Decreased plasma and extracellular volume in GH-deficient adults and the acute and prolonged effects of GH administration. A controlled experimental study, Clin. Endocrinol. Oxf. 44 (1996) 533-539.
90. J. Svensson, G. Johannsson, B.A. Bengtsson, Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test, Clin. Endocrinol. (Oxf.) 46 (1997) 579-586.
91. S.M. Orme, J.P. Sebastian, B. Oldroyd, S.P. Stewart, P.J. Grant, M.H. Stickland, M.A. Smith, P.E. Belchetz, Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy, Clin. Endocrinol. Oxf. 37 (1992) 453-459.
92. A. Binnerts, G.R. Swart, J.H.P. Wilson, N. Hoogerbrugge, H.A.P. Pols, J.C. Birkenhager, S.W.J. Lamberts, The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition, Clin. Endocrinol. Oxf. 37 (1992) 79-87.
93. J. Moller, J.O.L. Jørgensen, T. Laursen, J. Frystyk, R.W. Naeraa, H. Orskov, J.S. Christiansen, Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters, Clin. Endocrinol. Oxf. 39 (1993) 403-408.
94. G. Amato, C. Carella, S. Fazio, G. La Montagna, A. Cittadini, D. Sabatini, C. Marciano Mone, L. Sacca, A. Bellastella, Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses, J. Clin. Endocrinol. Metab. 77 (1993) 1671-1676.
95. N.K. Valk, Lely vd, A.J. Herder de, W.W. Lindemans, J. Lamberts, J. Clin. Endocrinol. Metab. 79 (1994) 1070-1076.
96. S.A. Beshyah, C. Freemantle, E. Thomas, B. Page, M. Murphy, D.G. Johnston, Comparison of measurements of body composition by total body potassium, bioimpedance analysis and dual-energy X-ray absortiometry in hypopituitary adults before and during growth hormone treatment, Am. J. Clin. Nutr. 61 (1995) 1186-1194.
97. S.A. Beshyah, C. Freemantle, M. Shahi, V. Anyaoku, S. Merson, S. Lynch, E. Skinner, P. Sharp, R. Foale, D.G. Johnston, Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults, Clin. Endocrinol. (Oxf.) 42 (1995) 73-84.
98. E.R. Christ, M.H. Cummings, N.B. Westwood, B.M. Sawyer, T.C. Pearson, P.H. Sonksen, D.L. Russel-Jones, The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency, J. Clin. Endocrinol. Metab. 82 (1997) 2985-2990.
99. F.J. Hayes, T.M. Fiad, T.J. McKenna, Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy, Metabolism 48 (1999) 308-313.
100. Y.E. Snel, R.J. Brummer, E. Bol, M.E. Doerga, P.M.J. Zelissen, M.L. Zonderland, P. Boer, H.A. Koomans, H.P.F. Koppeschaar, Direct assesment of extracellular water volume by the bromide-dilution method in growth hormone-deficient adults*, Eur. J. Clin. Invest. 25 (1995) 708-714.
101. D. van Wouters, W.D. van MarkenLichtenbelt, Y.E. Snel, R.J. Brummer, H.P. Koppeschaar, Deuterium and bromide dilution, and bioimpedance spectrometry independently show that growth hormone-deficient adults have an enlarged extracellular water compartment related to intracellular water, J. Clin. Endocrinol. Metab. 82 (1997) 907-911.
102. T. Falkheden, B. Sjogren, Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly, Acta. Endocrinol. Copenh. 46 (1964) 80-88.
103. G. Johannsson, R. Bjarnason, M. Bramnert, L.M. Carlsson, M. Degerblad, P. Manhem, T. Rosen, M. Thoren, B.A. Bengtsson, The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender, J. Clin. Endocrinol. Metab. 81 (1996) 1575-1581.
104. G. Johannsson, T. Rosen, B.A. Bengtsson, Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults, Clin. Endocrinol. (Oxf.) 47 (1997) 571-581.
105. J. Moller, A.M. Rosenfalch, S. Fisker, J.O.L. Jørgensen, J. Hilsted, J.S. Christiansen, The impact of 4 months GH substitution on body fluid distribution in adult GH deficient patients, Eur. J. Endocrinol. 140 (1999) 11-16.
106. K.A. Al-Shoumer, B. Page, F. Thomas, M. Murphy, S.A. Beshyah, D.G. Johnston, Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults, Eur. J. Endocrinol. 135 (1996) 559 567.
107. J. Verhelst, R. Abs, M. Vandeweghe, J. Mockel, J.J. Legros, G. Copinschi, C. Mahler, B. Velkeniers, L. Vanhaelst, A. Van Aelst, D. De Rijdt, A. Stevenaert, A. Beckers, Two years of replacement therapy in adults with growth hormone deficiency. Clin. Endocrinol. 47 (1997) 485-494.
108. R.C. Cuneo, S. Judd, J.D. Wallace, D. Perry-Keene, H. Burger, S. Lim-Tio, B. Strauss, J. Stockigt, D. Topliss, F. Alford, L. Hew, H. Bode, A. Conway, D. Handelsman, S. Dunn, S. Boyages, N.W. Cheung, D. Hurley, The australian multicenter trial of growth hormone (GH) treatment in GH deficient adults, J. Clin. Endocrinol. Metab. 83 (1998) 107-116.
109. J. Moller. J.O.L. Jørgensen, N. Moller, H. Stodkilde-Jorgensen, J.S. Christiansen, Assesment of fat and muscle volume and water content by magnetic resonance imaging (MRI) and proton spectroscopy in growth hormone (GH) deficient adults before and after GH treatment, Endocrinol. Metab. 1 (1994) 131-135.
110. T. Falkheden, B. Sjogren, H. Westling, Studies on the blood volume following hypophysectomy in man, Acta Endocrinol. Copenh. 42 (1963) 552-564.
111. J.H. Jepson, E.E. McGarry, Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone, Blood 39 (1972) 238-248.
112. O. Linderkamp, O. Butenandt, T. Mader, D. Knorr, K.P. Riegel, The effect of growth hormone deficiency and of growth hormone substitution on blood volume and red cell parameters, Pediat. Res. 11 (1977) 885-889.
113. D. Ikkos, H. Ljunggren, R. Luft, The relation between extracellular and intracellular water in acromegaly, Acta Endocrinol. Copenh. 21 (1956) 211-225.
114. A.R. McLellan. J.M. Connel, G.H. Beastall, G. Teasdale, D.L. Davies, Growth hormone, body composition and somatomedin C after treatment of acromegaly, Q. J. Med. 69(260) (1988) 997-1008.
115. B.A. Bengtsson, R.J. Brummer, S. Eden, I. Bosaeus, Body composition in acromegaly, Clin. Endocrinol. (Oxf.) 30 (1989) 121-130.
116. C.M. Ritchie, B. Sheridan, R. Fraser, D.R. Hadden, A.L. Kennedy, J. Riddell, A.B. Atkinson, Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly, Q. J. Med. 76 (1990) 855-867.
117. K. Landin, B. Petruson, K.E. Jakobsson, B.A. Bengtsson, Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure, Acta Endocrinol. (Copenh.) 128 (1993) 418-422.
118. A.J. O'Sullivan, J.J. Kelly, D.M. Hoffman, J. Freund, K.Y. Ho, Body composition and energy expenditure in acromegaly, J. Clin. Endocrinol. Metab. 78 (1994) 381-386.
119. T.B. Hansen, J. Gram, P. Bjerre, C. Hagen, J. Bollerslev. Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study, Clin. Endocrinol. (Oxf.) 41 (1994) 323-329.
120. E.Z. Hirsch, J.G. Sloman, F.I. Martin, Cardiac function in acromegaly, Am. J. Med. Sci. 257 (1969) 1-8.
121. G. Strauch, A. Lego, F. Therain, H. Bricaire, Reversible plasma and red blood cells volumes increases in acromegaly, Acta Endocrinol. Copenh. 85 (1977) 465-478.
122. G. Strauch, M.B. Vallotton, Y. Touitou, H. Bricaire, The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly, N. Engl. J. Med. 287 (1972) 795-799.
123. P. Chanson, J. Timsit, C. Masquet, A. Warnet, J.P. Guillausseau, P. Birman, A.G. Harris, J. Lubetzki, Cardiovascular effects of the somatostatin analolog octreotide in acromegaly, Ann. Int. Med. 113 (1990) 921-925.
124. G. Deray, P. Chanson, G. Maistre, A. Warnet, J. Eurin, C. Barthelemy, F.C. Masson, F. Martinez, J. Lubetzki, J.C. Legrand, C. Jacobs, Atrial natriuretic factor in patients with acromegaly, Eur. J. Clin. Pharmacol. 38 (1990) 409-413.
125. J.A. Miller, S.W. Tobe, K.L. Skorecki, Control of extracellular fluid volume and the pathophysiology of edema formation, in: B.M. Brenner (Ed.), The Kidney, WB Saunders, Philadelphia, 1996, pp. 817-872.
126. D. Haussinger, E. Roth, F. Lang, W. Gerok, Cellular hydration state: an important determinant of protein catabolism in health and disease, Lancet 341 (1993) 1330-1332.
127. M.O. Lee, N.K. Schaffer, Anterior pituitary growth hormone and the composition of growth, J. Nutr. 7 (1934) 337-363.
128. C.M. Glafkides, L.L. Bennett, Reduction of urinary sodium and potassium of diabetic rats produced by hypophyseal growth hormone, Proc. Soc. Exp. Biol. Med. 1951 (1951) 524-526.
129. J.E. Whitney, L.L. Bennett, C.H. Li, Reduction of urinary sodium and potassium produced by hypophyseal growth hormone in normal female rats, Proc. Soc. Exp. Biol. Med. 79 (1952) 584-587.
130. J. Stein, L.L. Bennett, A.A. Batts, C.H. Li, Sodium, potassium and chloride retention produced by growth hormone in the absence of the adrenals, Am. J. Physiol. 171 (1952) 587-591.
131. A.A. Batts, L.L. Bennett, J. Garcia, J. Stein, The effect of growth hormone on muscle potassium and on extracellular fluid, Endocrinology 55 (1954) 456-465.
132. E.H. Yenning, J. Dyrenfurth, G.J.P. Giroud, J.C. Beck, Effect of growth hormone on aldosterone excretion, Metabolism 5 (1956) 697-702.
133. E.H. Yenning, O.J. Lucis, Effect of growth hormone on the biosynthesis of aldosterone in the rat, Endocrinology 20 (1962) 486-491.
134. J.W. Finkelstein, A. Kowarski, J.S. Spaulding, C.J. Migeon, Effect of various preparations of human growth hormone on aldosterone secretion rate of hypopituitary dwarfs, Am. J. Med. 38 (1965) 517-521.
135. J.H. Ludens, R.R. Bach, H.E. Williamson, Characteristics of the antinatriuretic action of growth hormone, Proc. Soc. Exp. Biol. Med. 130 (1969) 1156-1158.
136. H. Herlitz, O. Jonsson, B.A. Bengtsson, Effect of recombinant human growth hormone on cellular sodium metabolism, Clin. Sci. Colch. 86 (1994) 233-237.
137. H. Herlitz, O. Jonsson, B.A. Bengtson, Relationship between plasma growth hormone concentration and cellular sodium transport in acromegaly, Acta Endocrinol. Copenh. 127 (1992) 38-43.
138. + pump, Clin. Sci. 95 (1998) 3-17.
139. Y. Shimomura, M. Lee, J. Oku, G.A. Bray, Z. Glick, Sodium-potassium dependent ATPase in hypophysectomized rats: response to growth hormone, triiodothyronine, and cortisone, Metabolism 31 (1982) 213-216.
140. M.E. Everts, I. Dorup, A. Flyvbjerg, S.M. Marshall, K.D. Jorgensen, Na(+)-K+ pump in rat muscle: effects of hypophysectomy, growth hormone, thyroid hormone, Am. J. Physiol. 259 (1990) E278-E283.
141. I. Dorup, A. Flyvbjerg, M.E. Everts, H. Orskov, Effects of growth hormone on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats, Am. J. Physiol. 262 (1992) E511-E517.
142. I. Dørup, T. Clausen, Insulin-like growth factor I stimulates active Na-K transport in rat soleus muscle, Am. J. Physiol. 268 (1995) E849-E857.
143. L.L. Ng, D.J. Evans, Leucocyte sodium transport in acromegaly, Clin. Endocrinol. Oxf. 26 (1987) 471-480.
144. F. Salomon, R.C. Cuneo, R. Hesp, J.F. Morris, L. Poston, P.H. Sonksen, Basal metabolic rate in adults with growth hormone deficiency and in patients with acromegaly: relationship with lean body mass, plasma insulin level and leucocyte sodium pump activity, Clin. Sci. 83 (1992) 325-330.
145. H.L. White, P. Heinbecker, D. Rolf, Enhancing effects of growth hormone on renal function, Am. J. Physiol. 157 (1949) 47-51.
146. R. Luft, B. Sjogren, The significance of the adenohypophysis, adrenal cortex, and thyroid in renal function in man, Acta Endocrinol. Copenh. 4 (1950) 351-362.
147. J.S. Christiansen, J. Gammelgaard, H. Orskov, A.R. Andersen, S. Telmer, H.H. Parving, Kidney function and size in normal subjects before and during growth hormone administration for one week, Eur. J. Clin. Invest. 11 (1981) 487-490.
148. R. Hirschberg, H. Rabb, R. Bergamo, J.D. Kopple, The delayed effect of growth hormone on renal function in humans, Kidney Int. 35 (1989) 865-870.
149. D. Haffner, E. Ritz, O. Mehls, J. Rosman, W. Blum, U. Heinrich, A. Hubinger, Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitors, Nephron 55 (1990) 63-68.
150. R. Hirschberg, J.D. Kopple, The effects of growth hormone and isulin-like growth factor I on renal glomerular and tubular function, in: A. Flyvbjerg, H. Ørskov, K.G.M.M. Alberti (Eds.), Growth Hormone and Insulin-like factorI, John Wiley, London, 1993, pp. 229-254.
151. H.H. Parving, I. Noer, C.E. Mogensen, P.A. Svendsen, Kidney function in normal man during short-term growth hormone infusion, Acta Endocrinol. Copenh. 89 (1978) 796-800.
152. H.P. Guler, K.U. Eckardt, J. Zapf, C. Bauer, E.R. Froesch, Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man, Acta Endocrinol. Copenh. 121 (1989) 101-106.
153. R. Hirschberg, G. Brunori, J.D. Kopple, H.P. Guler, Effects of insulin-like growth factor I on renal function in normal men, Kidney Int. 43 (1993) 387-397.
154. J. Haylor, I. Singh, A.M. Hahas, Nitric oxide synthesis
155. K.L. Skorecki, B.M. Brenner, Body fluid homeostasis in man, Am. J. Med. 70 (1981) 77-88.
156. M.D. Lindheimer, R.C. Lalone, N.G. Levinsky, Evidence that an acute increase in glomerular filtration has little effect on sodium excretion in the dog unless extracellular volume is expanded, J. Clin. Invest. 46 (1967) 256-265.
157. M.E. Gunning, J.R. Ingelfinger, A.J. King, B.M. Brenner, Vasoactive peptides and the kidney, in: B.M. Brenner (Ed.), The Kidney, WB Saunders, Philadelphia, 1996, pp. 627-712.
158. T.W. Honeyman, H.M. Goodman, J.C. Fray, The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats, Endocrinology 112 (1983) 1613-1617.
159. B. Wyse, M. Waters, C. Sernia, Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats, Am. J. Physiol. 265 (1993) E332-E339.
160. K.Y. Ho, A.J. Weissberger, The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system, Metabolism 39 (1990) 133-137.
161. R.C. Cuneo, F. Salomon, P. Wilmshurst, C. Byrne, C.M. Wiles, R. Hesp, P.H. Sonksen, Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system, Clin. Sci. 81 (1991) 587-592.
162. J.U. Weaver, L. Thaventhiran, K. Noonan, J.M. Burrin, N.F. Taylor, M.R. Norman, J.P. Monson, The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults, Clin. Endocrinol. Oxf. 41 (1994) 639-648.
163. E.J. Ross, W. van't Hoff, J. Crabbe', G.W. Thorn, Aldosterone excretion in hypopituitarism and after hypophysectomy in man, Am. J. Med. 62 (1960) 229-238.
164. H. Monig, M. Peter, W.G. Sippell, Hyporeninaemic hypoaldosteronism after growth hormone treatment [letter], Lancet 347 (1996) 119-119.
165. M. Krogsgaard Thomsen, C. Friis, B. Sehested Hansen, P. Johansen, C. Eschen, J. Nowak, K. Poulsen, Studies on the renal kinetics of growth hormone (GH) and on the GH receptor and related effects in animals, J. Pediatr. Endocrinol. 7 (1994) 93-105.
166. M. Birkhauser, R. Gaillard, A.M. Riondel, G.R. Zahnd, Influence of acute administration of growth hormone and α-MSH on plasma concentrations of aldosterone, cortisol, corticosterone and growth hormone in man, Acta. Endocrinol. Copenh. 79 (1975) 16-24.
167. J.S. Barton, P.C. Hindmarsh, M.A. Preece, C.G.D. Brook, Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone, Clin. Endocrinol. 38 (1993) 245-251.
168. J. DiMartino-Nardi, S. Wesoly, L. Schwartz, P. Saenger, Lack of clinical evidence of sodium retention in children with idiopathic short stature treated with recombinant growth hormone, Metabolism 42 (1993) 730-734.
169. J.H. Pratt, M. Peacock, D.P. Henry, Effect of recombinant human growth hormone on adreno-cortical function, and on sodium and potassium homeostasis, Pharmacology 47 (1993) 36-42.
170. R.E. Mccaa, J.M. Montalvo, C.S. Mccaa, Role of growth hormone in the regulation of aldosterone biosynthesis, J. Clin. Endocrinol. Metab. 46 (1978) 247-253.
171. K. Caidahl, S. Eden, B.A. Bengtsson, Cardiovascular and renal effects of growth hormone, Clin. Endocrinol. Oxf. 40 (1994) 393-400.
172. J.P. Cain, G.H. Williams, R.G. Dluhy, Plasma renin activity and aldosterone secretion in patients with acromegaly, J. Clin. Endocrinol. Metab. 34 (1972) 73-81.
173. C. Kraatz, G. Benker, F. Weber, D. Ludecke, H. Hirche, D. Reinwein, Acromegaly and hypertension: prevalence and relationship to the renin- angiotensin-aldosterone system, Klin. Wochenschr. 68 (1990) 583-587.
174. F. Mantero, G. Opocher, D. Armanini, G. Paviotti, M. Boscaro, M. Muggeo, Plasma renin and urinary aldosterone in acromegaly, J. Endocrinol. Invest. 2 (1979) 13-18.
175. B.E. Karlberg, A.M. Ottosson, Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system, Acta Endocrinol. Copenh. 100 (1982) 581-587.
176. F.J. Hayes, T.M. Fiad, T.J. McKenna, Activity of the renin-angiotensin-aldosterone axis is dependent on the occurrence of edema in growth hormone (GH)-deficient adults treated with GH, J. Clin. Endocrinol. Metab. 82 (1997) 322-323.
177. J. Møller, J.O. Jorgensen, J. Marqversen, E. Frandsen, J.S. Christiansen, Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor. Clin. Endocrinol. (Oxf.) (1999), in press.
178. A. Flyvbjerg, S. Nielsen, M.I. Sheikh, C. Jacobsen, H. Orskov, E.I. Christensen, Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules, Am. J. Physiol. 265 (1993) F624-F633.
179. R. Quigley, M. Baum, Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport, J. Clin. Invest. 88 (1991) 368-374.
180. J.T. August, D.H. Nelson, G.W. Thorn, Response of normal subjects to large amounts of aldosterone, J. Clin. Invest. 37 (1958) 1549-1555.
181. R.S. Zimmerman, B.S. Edwards, T.R. Schwab, D.M. Heublein, J.C.J. Burnett, Atrial natriuretic peptide during mineralocorticoid escape in the human, J. Clin. Endocrinol. Metab. 64 (1987) 624-627.
182. A.J. de Bold, H.B. Borenstein, A.T. Veress, H. Sonnenberg, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sci. 28 (1981) 89-94.
183. R.E. Lang, H. Tholken, D. Ganten, F.C. Luft, H. Ruskoaho, T. Unger, Atrial natriuretic factor-a circulating hormone stimulated by volume loading, Nature 314 (1985) 264-266.
184. J.H. Laragh, Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis, N. Engl. J. Med. 313 (1985) 1330-1340.
185. E.A. Espiner, A.M. Richards, Atrial natriuretic peptide. An important factor in sodium and blood pressure regulation, Lancet 1 (1989) 707-710.
186. C.J. Kenyon, A.G. Jardine, Water and Salt Homeostasis in Health and Disease, Bailliere Tindall, London, 1989, 431 pp.
187. J.A. McKnight, D.R. McCance, D.R. Hadden, L. Kennedy, G. Roberts, B. Sheridan, A.B. Atkinson, Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly, Clin. Endocrinol. Oxf. 31 (1989) 431-438.
188. P. Soszynski, J. Slowinska-Srzednicka, S. Zgliczynski, Plasma concentrations of atrial natriuretic hormone in acromegaly: relationship to hypertension, Acta Endocrinol. Copenh. 125 (1991) 268-272.
189. C. Hall, J.L. Rouleau, L. Moye, J. de Champlain, D. Bichet, M. Klein, B. Sussex, M. Packer, J. Rouleau, M.O. Arnold, G.A. Lamas, F. Sestier, S.S. Gotlieb, C.-C.C. Wun, M.A. Pfeffer, N-terminal proatrial natriuretic factor, Circulation 89 (1994) 1934-1942.
190. B.A. Harder, M.C. Schaub, H.M. Eppenberger, M. Eppenberger-Eberhardt, Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture, J. Mol. Cell. Cardiol. 28 (1996) 19-31.
191. M.Y. Donath, M.A. Gostelli-Peter, C. Hauri, E.R. Froesch, J. Zapf, Insulin-like growth factor-I stimulates myolibrillar genes and modulates atrial natriuretic mRNA in rat heart, Eur. J. Endocrinol. 137 (1997) 309-315.
192. M.Y. Donath, W. Zierhut, M.A. Gostelli-Peter, C. Hauri, E.R. Froesch, J. Zapf, Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat, Eur. J. Endocrinol. 139 (1998) 109-117.
193. V.M. Dirsch, E. Wolf, R. Wanke, R. Schulz, W. Hermanns, A.M. Vollmar, Effects of chronic GH overproduction on cardiac ANP expression and circulating ANP levels, Mol. Cell. Endocrinol. 144 (1998) 109-118.
194. J. Timsit, B. Riou, J. Bertherat, C. Wisnewsky, N.S. Kato, A.S. Weisberg, J. Lubetzki, Y. Lecarpentier, S. Winegrad, J.J. Mercadier, Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle, J. Clin. Invest. 86 (1990) 507-515.
195. L. Thuesen, J.S. Christiansen, K.E. Sorensen, J.O. Jorgensen, H. Orskov, P. Henningsen, Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study, Dan. Med. Bull. 35 (1988) 193-196.
196. A. Cittadini, A. Cuocolo, B. Merola, S. Fazio, D. Sabatini, E. Nicolai, A. Colao, S. Longobardi, G. Lombardi, L. Sacca, Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement, Am. J. Physiol. 267 (1994) E219-E225.
197. M.Y. Donath, R. Jenni, H.P. Brunner, M. Anrig, S. Kohli, Y. Glatz, E.R. Froesch, Cardiovascular and metabolic effects of insulin-like growth factor-I at rest and during exercise in humans, J. Clin. Endocrinol. Metab. 81 (1996) 4089-4094.
198. M.Y. Donath, G. Sutsch, Y. Xia-Wei, B. Piva, H.P. Brunner, Y. Glatz, J. Zapf, F. Follath, E.R. Froesch, W. Kiowski, Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure, J. Clin. Endocrinol. Metab. 83 (1998) 3177-3183.
199. L.R. Donahue, G. Watson, W.G. Beamer, Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice, J. Endocrinol. 139 (1993) 431-439.
200. N. Jabri, D.S. Schalch, S.L. Schwartz, J.S. Fischer, M.S. Kipnes, B.J. Radnik, N.J. Turman, V.S. Marcsisin, H.P. Guler, Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients, Diabetes 43 (1994) 369-374.
201. J.L. Thompson, G.E. Butterfield, R. Marcus, R. Hintz, M. Van Loan, L. Ghiron, A.R. Hoffman, The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women, J. Clin. Endocrinol. Metab. 80 (1995) 1845-1852.
202. J.D. Kopple, H. Ding, R. Hirschberg, Effects of recombinant human insulin-like growth factor I on renal handling of phosphorus, calcium and sodium in normal humans, Am. J. Kidney Dis. 26 (1995) 818-824.
203. M. Giordano, R.A. DeFronzo, Acute effects of human insulin-like growth factor I on renal functions in humans, Nephron 71 (1995) 10-15.
204. J.L. Walker, M. Ginalska-Malinowska, T.E. Romer, J.B. Pucilowska, L.E. Underwood, Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism), N. Engl. J. Med. 324 (1991) 1483-1488.
205. K.Y. Ho, A.J. Weissberger, M.C. Stuart, R.O. Day, L. Lazarus, The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects, Clin. Endocrinol. Oxf. 30 (1989) 335-345.
206. J.P. Fillastre, R. Ardaillou, R. Isaac, Influence of extracellular volume expansion on the composition of proximal tubular fluid in man, Clin. Sci. 40 (1971) 479-486.
207. P.R. Bratusch Marrain, D. Smith, R.A. DeFronzo, The effect of growth hormone on glucose metabolism and insulin secretion in man, J. Clin. Endocrinol. Metab. 55 (1982) 973-982.
208. N. Moller, O. Schmitz, J.O. Jorgensen, J. Astrup, J.F. Bak, S.E. Christensen, K.G. Alberti, J. Weeke, Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy, J. Clin. Endocrinol. Metab. 74 (1992) 1012-1019.
209. N. Moller, J. Moller, J.O. Jorgensen, P. Ovesen, O. Schmitz, K.G. Alberti, J.S. Christiansen, Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans, Clin. Endocrinol. Oxf. 39 (1993) 577-581.
210. R.A. DeFronzo, The effect of insulin on renal sodium metabolism, Diabetol. J. 21 (1981) 165-171.
211. E. Feraille, M. Rousselot, R. Rajerison, H. Favre, Effect of insulin on Na+,K(+)-ATPase in rat collecting duct, J. Physiol. (Lond.) 488 (1995) 171-180.
212. H.J. Arnqvist, B.J. Ballermann, G.L. King, Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells, Am. J. Physiol. 254 (1988) C411-C416.
213. M. Korbonits, G. Kaltsas, L.A. Perry, P. Putignano, A.B. Grossman, G.M. Besser, P.J. Trainer, The growth hormone secretagogue hexarelin stimulates the hypothalamo- pituitary-adrenal axis via arginine vasopressin, J. Clin. Endocrinol. Metab. 84 (1999) 2489-2495.
214. S. Nielsen, T.H. Kwon, B.M. Christensen, D. Promeneur, J. Frokiaer, D. Marples, Physiology and pathophysiology of renal aquaporins, J. Am. Soc. Nephrol. 10 (1999) 647-663.
215. C.B. Nielsen, S.S. Sorensen, E.B. Pedersen, Identical effects of indomethacin on renal function in healthy uninephrectomized subjects and in healthy control subjects, Clin. Sci. 36 (1994) 715-721.
216. R. Hirschberg, J.D. Kopple, Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats, J. Clin. Invest. 83 (1989) 326-330.
217. R. Franco-Saenz, S. Suzuki, S.Y. Tan, P.J. Mulrow, Prostaglandin stimulation of renin release: Independence of β-adrenergic receptor activity and possible mechanism of action, Endocrinology 106 (1980) 1400-1405.
218. B. Tonshoff, F.J. Kaskel, L.C. Moore, Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature, Am. J. Physiol. 274 (1998) F120-F128.
219. N. Moller, J.O. Jorgensen, O. Schmitz, J. Moller, J. Christiansen, K.G. Alberti, H. Orskov, Effects of a growth hormone pulse on total and forearm substrate fluxes in humans, Am. J. Physiol. 258 (1990) E86-E91.
220. G-monomethyl-L-arginine inhibits the blood flowbut not the insulin-like response of forearm muscle to IGF-I, J. Clin. Invest. 97 (1996) 1319-1328.
221. E.R. Christ, P.J. Chowienczyk, P.H. nksen, D.L. Russel-Jones, Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity, Clin. Endocrinol. (Oxf.) 51 (1999) 21-25.
222. S. Gambaryan, C. Hausler, T. Markert, D. Pohler, T. Jarchau, U. Walter, W. Haase, A. Kurtz, S.M. Lohmann, Expression of type II cGMP dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression, J. Clin. Invest. 98 (1996) 662-670.
223. J.C.T. Maaten, H. De Boer, O. Kamp, L. Stuurman, E.A. van der Veen, Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency, J. Clin. Endocrinol. Metab. 84 (1999) 2373-2380.
224. L.Y. Matsouka, J. Wortsman, C.E. Kupchella, A. Eng, J.E. Dietrich, Histochemical characterization of the cutaneous involvement of acromegaly, Arch. Intern. Med. 142 (1982) 1820-1823.
225. J.J. Zachwieja, D.M. Bier, K.E. Yarasheski, Growth hormone administration in older adults: effects on albumin synthesis, Am. J. Physiol. Endocrinol. 266 (29) (1994) E840-E844.
226. N. Rossing, H.H. Parving, O. Korsgaard, Metabolism and transcapillary escape rate of albumin in acromegaly, Scand. J. Clin. Lab. Invest. 33 (1974) 39-44.
227. M.A. McNurlan, P.J. Garlick, R.A. Frost, K.A. Decristofaro, C.H. Lang, R.T. Steigbigel, J. Fuhrer, M. Gelato, Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: differential effects of growth hormone administration, J. Clin. Endocrinol. Metab. 83 (1998) 3050-3055.
228. J. Ingerslev, P.D. Christensen, S. Stenbjerg, N. Moller, H. Orskov, J.S. Christiansen, Diabetes-like alterations in hemostatic parameters after growth hormone administration for one week in normal man, J. Diabetes Complications 3 (1989) 103-106.
229. J.O. Jorgensen, S.A. Pedersen, J. Ingerslev, J. Moller, N.E. Skakkebaek, J.S. Christiansen, Growth hormone (GH) therapy in GH-deficient patients, the plasma factor VIII von Willebrand factor complex, and capillary fragility. A double-blind, placebo-controlled crossover study, Scand. J. Clin. Lab. Invest. (1990).